These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17196505)

  • 1. Effect of finasteride on prostate-specific antigen.
    Nadler RB
    Lancet Oncol; 2007 Jan; 8(1):4-5. PubMed ID: 17196505
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.
    D'Amico AV; Roehrborn CG
    Lancet Oncol; 2007 Jan; 8(1):21-5. PubMed ID: 17196507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
    Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
    Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selections from current literature: androgenetic alopecia: the science behind a new oral treatment.
    Baumann LS; Kelso EB
    Fam Pract; 1998 Oct; 15(5):493-6. PubMed ID: 9848437
    [No Abstract]   [Full Text] [Related]  

  • 5. Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia.
    Kang HW; Chae MH; Park SH; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Yoon TY; Kim WJ
    J Urol; 2017 Dec; 198(6):1340-1345. PubMed ID: 28743526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
    Drake L; Hordinsky M; Fiedler V; Swinehart J; Unger WP; Cotterill PC; Thiboutot DM; Lowe N; Jacobson C; Whiting D; Stieglitz S; Kraus SJ; Griffin EI; Weiss D; Carrington P; Gencheff C; Cole GW; Pariser DM; Epstein ES; Tanaka W; Dallob A; Vandormael K; Geissler L; Waldstreicher J
    J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of prostate cancer with finasteride.
    Burke HB
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562806
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen level.
    Coltman CA
    Br J Cancer; 1999 Sep; 81(1):184-5. PubMed ID: 10487632
    [No Abstract]   [Full Text] [Related]  

  • 9. Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
    Lin JH; Chen WC
    Kaohsiung J Med Sci; 2002 Aug; 18(8):379-85. PubMed ID: 12476680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].
    Spinucci G; Pasquali R
    Clin Ter; 1996 Jun; 147(6):305-15. PubMed ID: 8925640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finasteride for female androgenetic alopecia.
    Thai KE; Sinclair RD
    Br J Dermatol; 2002 Oct; 147(4):812-3. PubMed ID: 12366441
    [No Abstract]   [Full Text] [Related]  

  • 12. Androgenetic alopecia: overview.
    Sawaya ME
    J Cutan Med Surg; 1999 Nov; 3 Suppl 3():S14-20. PubMed ID: 11749885
    [No Abstract]   [Full Text] [Related]  

  • 13. Guideline supports long-term use of medication to lower prostate cancer risk.
    Mitka M
    JAMA; 2009 May; 301(17):1753-4. PubMed ID: 19417182
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of prostate cancer with finasteride.
    Ross RK; Skinner E; Cote RJ
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562807
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate cancer prevention and finasteride.
    D'Amico AV; Barry MJ
    J Urol; 2006 Nov; 176(5):2010-2; discussion 2012-3. PubMed ID: 17070238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential application of finasteride for chemoprevention of prostate cancer.
    Gormley GJ; Brawley O; Thompson I
    Ann N Y Acad Sci; 1995 Sep; 768():163-9. PubMed ID: 8526345
    [No Abstract]   [Full Text] [Related]  

  • 17. 5 alpha-reductase and finasteride in pattern alopecia and acne.
    Burkhart CG; Burkhart CN
    J Drugs Dermatol; 2004; 3(4):363-4. PubMed ID: 15303779
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of men on finasteride.
    Gormley GJ
    Semin Urol Oncol; 1996 Aug; 14(3):139-44. PubMed ID: 8865475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone.
    Kohler C; Tschumi K; Bodmer C; Schneiter M; Birkhaeuser M
    Gynecol Endocrinol; 2007 Mar; 23(3):142-5. PubMed ID: 17454167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women.
    Trüeb RM;
    Dermatology; 2004; 209(3):202-7. PubMed ID: 15459533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.